News | January 28, 2007

Imaging, Technology Innovations Shared with Bypass Surgeons

Jan. 29, 2007 — Novadaq Technologies Inc. and Apple Inc. presented new technologies to about 100 heart surgeons Sunday evening, Jan. 28, in San Diego. Gathering members of the Society of Thoracic Surgeons, whose annual meeting is convening at the San Diego Convention Center through Jan. 31, the program featured Novadaq’s SPY Intra-operative Imaging System, a real-time visual imaging device for use during heart bypass surgery. Apple shared how its technologies are being used in medicine and how the iPod is facilitating personal and portable medical media.

"We are delighted that Apple co-sponsored this event with Novadaq," said Dr. Arun Menawat, President and Chief Executive Officer Novadaq Technologies Inc. "Novadaq's innovations are providing medical imaging for the operating room to improve clinical outcomes and Apple is the leader of innovation in the personal computing industry. It's a synergistic fit between technologies and a perfect opportunity for cardiac surgeons to see and participate in the imaging revolution."

Speakers presented on how new technology is helping doctors use imaging in new ways to help patients and educated cardiac surgeons about Apple technology in medicine.

The SPY System is the first and only fluorescent imaging system FDA cleared for use in coronary artery bypass surgery. SPY enables cardiac surgeons to simply and efficiently assess the quality of blood flow through the heart during surgery.


Related Content

News | Pharmaceuticals

July 10, 2024 — Reviva Pharmaceuticals Holdings, Inc., a late-stage pharmaceutical company developing therapies that ...

Home July 10, 2024
Home
News | Pharmaceuticals

June 5, 2024 — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced a new post-hoc analysis of clinical data ...

Home June 05, 2024
Home
News | Pharmaceuticals

May 24, 2024 — Lexicon Pharmaceuticals, Inc. announced a new post-hoc analysis of clinical data showing that INPEFA ...

Home May 24, 2024
Home
News | Pharmaceuticals

May 6, 2024 — Tenax Therapeutics, Inc., a Phase 3, development-stage pharmaceutical company focused on identifying ...

Home May 06, 2024
Home
News | Pharmaceuticals

February 16, 2024 — AMO Pharma Limited, a privately held clinical-stage specialty biopharmaceutical company focusing on ...

Home February 16, 2024
Home
News | Pharmaceuticals

January 25, 2024 — Agepha Pharma, a leading multinational pharmaceutical company with the first FDA-approved anti ...

Home January 25, 2024
Home
News | Pharmaceuticals

November 21, 2023 — BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases and ...

Home November 21, 2023
Home
Feature | Pharmaceuticals | By Christine Book

In a new 3-part video series on hypertrophic cardiomyopathy with Christine E. Seidman, MD, FACC, FAHA, Managing Editor ...

Home October 25, 2023
Home
Videos | Pharmaceuticals

In this third and final segment in DAIC’s “One on One” series with Dr. Christine Seidman, learn what’s on the horizon at ...

Home September 26, 2023
Home
Subscribe Now